Impact of a Genetic Polymorphism of the Interleukin-1 Receptor Antagonist on Technique Survival in Peritoneal Dialysis Patients

Publisher： Karger

E-ISSN： 1421-9735|23|6|450-458

ISSN： 0253-5068

Source： Blood Purification, Vol.23, Iss.6, 2005-12, pp. : 450-458

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association of Interleukin-1β Gene Polymorphism and Peritonitis in Uremic Patients Undergoing Peritoneal Dialysis

By  

Blood Purification, Vol. 32, Iss. 3, 2011-06 ,pp. : 156-160

Karger

Access to resources Recommend Favorite

The Impact of Strict Volume Control Strategy on Patient Survival and Technique Failure in Peritoneal Dialysis Patients

By  

Blood Purification, Vol. 32, Iss. 1, 2011-02 ,pp. : 30-37

Karger

Access to resources Recommend Favorite

Association of Interleukin-1 Receptor Antagonist Gene Polymorphism with IgA Nephropathy

By  

Nephron, Vol. 91, Iss. 4, 2002-07 ,pp. : 744-746

Karger

Access to resources Recommend Favorite

Cysteinyl 1 Receptor Antagonist Montelukast, Does Not Prevent Peritoneal Membrane Damage in Experimental Chronic Peritoneal Dialysis Model in Rats

By  

Kidney and Blood Pressure Research, Vol. 39, Iss. 6, 2014-12 ,pp. : 648-657

Karger

Access to resources Recommend Favorite

Impact of Baseline Health-Related Quality of Life Scores on Survival of Incident Patients on Peritoneal Dialysis: A Cohort Study

By  

Nephron, Vol. 129, Iss. 2, 2015-01 ,pp. : 97-103

Karger

Access to resources Recommend Favorite